CoChat
Sign Up
Cited by 24Diabetes Treatment and ManagementDiabetes Management and ResearchPharmaceutical Practices and Patient Outcomes

Approaches to risk assessment among older patients with diabetes

Open access
Pilla, Scott J., Schoenborn, Nancy L., Maruthur, Nisa M., Huang, Elbert S.·2019·Current Diabetes Reports
DOI 10.1007/s11892-019-1172-zPMC PMC7307417
Open this paper in CoChat — free account

Abstract

Purpose of review A patient's prognosis and risk of adverse drug effects are important considerations for individualizing care of older patients with diabetes. This review summarizes the evidence for risk assessment and proposes approaches for clinicians in the context of current clinical guidelines. Recent findings Diabetes guidelines vary in their recommendations for how life expectancy should be estimated and used to inform the selection of glycemic targets. Readily available prognostic tools may improve estimation of life expectancy but require validation among patients with diabetes. Treatment decisions based on prognosis are difficult for clinicians to communicate and for patients to understand. Determining hypoglycemia risk involves assessing major risk factors; models to synthesize these factors have been developed. Applying risk assessment to individualize diabetes care is complex and currently relies heavily on clinician judgment. More research is need to validate structured approaches to risk assessment and determine how to incorporate them into patient-centered diabetes care.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11892-019-1172-z

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Multiple prognostic tools for life expectancy for older adults are available.

    “Multiple prognostic tools for life expectancy for older adults are available (60,61).”

    From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [60]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 111

  1. American Diabetes Association. 6. Glycemic targets: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1): S61– 70. 10.2337/dc19-S006. 30559232 ADA standards of care, section includes individualized glycemic targets. · DOI · Paper page
  2. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1): S90– S102. 10.2337/dc19-S009. 30559235 ADA standards of care, section includes individualized medication selection. · DOI · Paper page
  3. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1): S13– 28. 10.2337/dc19-S002. 30559228 ADA standards of care for older adults. · DOI
  4. [4]American Geriatrics Society Expert Panel on Care of Older Adults with Diabetes Mellitus, Moreno G, Mangione CM, Kimbro L, Vaisberg E. Guidelines abstracted from the American Geriatrics Society guidelines for improving the care of older adults with diabetes mellitus: 2013 update. J Am Geriatr Soc. 2013; 61(11): 2020– 6. 10.1111/jgs.12514. 24219204 PMC4064258 · DOI
  5. [5]Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Manas L, European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab. 2011; 37 Suppl 3: S27– 38. 10.1016/S1262-3636(11)70962-4. 22183418 · DOI · Paper page
  6. Conlin PR, Colburn J, Aron D, Pries RM, Tschanz MP, Pogach L. Synopsis of the 2017 U.S. Department of Veterans Affairs/U.S. Department of Defense clinical practice guideline: management of type 2 diabetes mellitus. Ann Intern Med. 2017; 167(9): 655– 63. 10.7326/M17-1362. 29059687 Veterans Affairs diabetes guidelines. · DOI
  7. LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, Treatment of diabetes in older adults: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab. 2019 10.1210/jc.2019-00198. PMC7271968 30903688 Endocrine Society diabetes guidelines for older adults. · DOI
  8. [8]Hemingway H, Croft P, Perel P, Hayden JA, Abrams K, Timmis A, Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ. 2013; 346: e5595 10.1136/bmj.e5595. 23386360 PMC3565687 · DOI
  9. [9]Schneider KM, O’Donnell BE, Dean D. Prevalence of multiple chronic conditions in the United States’ Medicare population. Health Qual Life Outcomes. 2009; 7: 82 10.1186/1477-7525-7-82. 19737412 PMC2748070 · DOI
  10. [11]Ostchega Y, Harris TB, Hirsch R, Parsons VL, Kington R. The prevalence of functional limitations and disability in older persons in the US: data from the National Health and Nutrition Examination Survey III. J Am Geriatr Soc. 2000; 48(9): 1132– 5. 10983915
  11. [12]Kalyani RR, Saudek CD, Brancati FL, Selvin E. Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999–2006. Diabetes Care. 2010; 33(5): 1055– 60. 10.2337/dc09-1597. 20185736 PMC2858174 · DOI · Paper page
  12. [13]Blaum C, Cigolle CT, Boyd C, Wolff JL, Tian Z, Langa KM, Clinical complexity in middle-aged and older adults with diabetes: the Health and Retirement Study. Med Care. 2010; 48(4): 327– 34. 20355264 PMC3153504
  13. [15]Smith AK, Williams BA, Lo B. Discussing overall prognosis with the very elderly. N Engl J Med. 2011; 365(23): 2149– 51. 10.1056/NEJMp1109990. 22150033 PMC3760676 · DOI
  14. [16]American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the American Geriatrics Society: American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. J Am Geriatr Soc. 2012; 60(10): 1957– 68. 10.1111/j.1532-5415.2012.04187.x. 22994844 PMC4459791 · DOI
  15. [17]Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012; 29(6): 453– 62. 10.2165/11631760-000000000-00000. 22642780 · DOI
  16. [18]Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014; 174(7): 1116– 24. 10.1001/jamainternmed.2014.1824. 24838229 PMC4152370 · DOI
  17. [19]Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011; 365(21): 2002– 12. 10.1056/NEJMsa1103053. 22111719 · DOI
  18. [20]Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients’ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med. 2014; 174(8): 1227– 34. 10.1001/jamainternmed.2014.2894. 24979148 PMC4299865 · DOI · Paper page
  19. [21]Huang ES, Shook M, Jin L, Chin MH, Meltzer DO. The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006; 29(2): 259– 64. 16443870 PMC2292131
  20. [22]Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemio-logical analysis of the ACCORD study. BMJ. 2010; 340: b5444 10.1136/bmj.b5444. 20061360 PMC2803743 · DOI · Paper page
  21. [23]Cigolle CT, Kabeto MU, Lee PG, Blaum CS. Clinical complexity and mortality in middle-aged and older adults with diabetes. J Gerontol A Biol Sci Med Sci. 2012; 67(12): 1313– 20. 10.1093/gerona/gls095. 22492022 PMC3670162 · DOI · Paper page
  22. American Diabetes Association. 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(Suppl 1): S34– 45. 10.2337/dc19-S004. 30559230 ADA standards of care, section includes risk factors for hypoglycemia. · DOI
  23. [25]Berkowitz SA, Aragon K, Hines J, Seligman H, Lee S, Sarkar U. Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? A systematic review. Health Serv Res. 2013; 48(4): 1299– 310. 10.1111/1475-6773.12048. 23445498 PMC3725526 · DOI
  24. [26]UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352(9131): 854– 65. 9742977
  25. [27]Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15): 1577– 89. 10.1056/NEJMoa0806470. 18784090 · DOI · Paper page
  26. [28]Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24): 2545– 59. 10.1056/NEJMoa0802743. 18539917 PMC4551392 · DOI · Paper page
  27. [29]ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358(24): 2560– 72. 10.1056/NEJMoa0802987. 18539916 · DOI · Paper page
  28. [30]Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med. 2014; 371(15): 1392– 406. 10.1056/NEJMoa1407963. 25234206 · DOI · Paper page
  29. [31]Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009; 360(2): 129– 39. 10.1056/NEJMoa0808431. 19092145 · DOI · Paper page
  30. [33]Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasquin B, Sanchez-Castellano C, Sanchez-Garcia E. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc. 2013; 61(5): 734– 8. 10.1111/jgs.12215. 23590338 · DOI
  31. Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2016; 164(11)): 740– 51. 10.7326/M15-2650. 27088241 Reviews the comparative effectiveness of diabetes medications. · DOI · Paper page
  32. Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017; 377(7): 644– 57. 10.1056/NEJMoa1611925. 28605608 Demonstrated cardiovascular benefit of canagliflozin. · DOI · Paper page
  33. [39]Holmes HM, Min LC, Yee M, Varadhan R, Basran J, Dale W, Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging. 2013; 30(9): 655– 66. 10.1007/s40266-013-0095-7. 23749475 PMC3755031 · DOI
  34. [40]Reuben DB. Medical care for the final years of life: “when you’re 83, it’s not going to be 20 years”. JAMA. 2009; 302(24): 2686– 94. 10.1001/jama.2009.1871. 20040557 PMC2822435 · DOI
  35. [41]Higginson IJ, Costantini M. Accuracy of prognosis estimates by four palliative care teams: a prospective cohort study. BMC Palliat Care. 2002; 1(1): 1. 11876829 PMC88964
  36. [42]Kong DF, Lee KL, Harrell FE Jr, Boswick JM, Mark DB, Hlatky MA, Clinical experience and predicting survival in coronary disease. Arch Intern Med. 1989; 149(5): 1177– 81. 2719510
  37. [43]Christakis NA, Lamont EB. Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ. 2000; 320(7233): 469– 72. 10678857 PMC27288
  38. [44]Vigano A, Dorgan M, Bruera E, Suarez-Almazor ME. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer. 1999; 86(1): 170– 6. 10391577
  39. [45]Maltoni M, Amadori D. Prognosis in advanced cancer. Hematol Oncol Clin North Am. 2002; 16(3): 715– 29. 12170577
  40. [46]Warraich HJ, Allen LA, Mukamal KJ, Ship A, Kociol RD. Accuracy of physician prognosis in heart failure and lung cancer: comparison between physician estimates and model predicted survival. Palliat Med. 2016; 30(7): 684– 9. 10.1177/0269216315626048. 26769732 · DOI
  41. [47]Porensky EK, Carpenter BD. Breaking bad news: effects of fore-casting diagnosis and framing prognosis. Patient Educ Couns. 2016; 99(1): 68– 76. 10.1016/j.pec.2015.07.022. 26238257 · DOI
  42. [48]Arias A United States life tables, 2008. Hyattsville: Center for Health Statistics; 2012 Contract No. 3 24974590
  43. [49]Minne L, Ludikhuize J, de Rooij SE, Abu-Hanna A. Characterizing predictive models of mortality for older adults and their validation for use in clinical practice. J Am Geriatr Soc. 2011; 59(6): 1110– 5. 10.1111/j.1532-5415.2011.03411.x. 21649618 · DOI
  44. Schoenborn NL, Bowman TL 2nd, Cayea D, Pollack CE, Feeser S, Boyd C. Primary care practitioners’ views on incorporating long-term prognosis in the care of older adults. JAMA Intern Med. 2016; 176(5): 671– 8. 10.1001/jamainternmed.2016.0670. 27064895 PMC5564293 Identified clinician barriers to applying prognosis in primary care. · DOI
  45. O’Hanlon CE, Cooper JM, Lee SM, John P, Churpek M, Chin MH, Life expectancy predictions for older diabetic patients as estimated by physicians and a prognostic model. MDM Policy Pract. 2017; 2(1): 2381468317713718 10.1177/2381468317713718. 30288423 PMC6124930 Demonstrated that physician- and model-estimated life expectancy for patients with diabetes can complement each other. · DOI
  46. [54]Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011; 64(7): 749– 59. 10.1016/j.jclinepi.2010.10.004. 21208778 PMC3100405 · DOI · Paper page
  47. [55]Mazzaglia G, Roti L, Corsini G, Colombini A, Maciocco G, Marchionni N, Screening of older community-dwelling people at risk for death and hospitalization: the Assistenza Socio-Sanitaria in Italia project. J Am Geriatr Soc. 2007; 55(12): 1955– 60. 10.1111/j.1532-5415.2007.01446.x. 17944891 PMC2669304 · DOI
  48. [56]Carey EC, Walter LC, Lindquist K, Covinsky KE. Development and validation of a functional morbidity index to predict mortality in community-dwelling elders. J Gen Intern Med. 2004; 19(10): 1027– 33. 10.1111/j.1525-1497.2004.40016.x. 15482555 PMC1492580 · DOI
  49. [57]Carey EC, Covinsky KE, Lui LY, Eng C, Sands LP, Walter LC. Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc. 2008; 56(1): 68– 75. 10.1111/j.1532-5415.2007.01496.x. 18031487 · DOI
  50. [58]Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA. 2006; 295(7): 801– 8. 10.1001/jama.295.7.801. 16478903 · DOI · Paper page
  51. [59]Cruz M, Covinsky K, Widera EW, Stijacic-Cenzer I, Lee SJ. Predicting 10-year mortality for older adults. JAMA. 2013; 309(9): 874– 6. 10.1001/jama.2013.1184. PMC3760279 23462780 · DOI
  52. [60]Lee SJ, Boscardin WJ, Kirby KA, Covinsky KE. Individualizing life expectancy estimates for older adults using the Gompertz Law of Human Mortality. PLoS One. 2014; 9(9): e108540 10.1371/journal.pone.0108540. 25265291 PMC4180452 · DOI
  53. [62]Schonberg MA, Davis RB, McCarthy EP, Marcantonio ER. External validation of an index to predict up to 9-year mortality of community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2011; 59(8): 1444– 51. 10.1111/j.1532-5415.2011.03523.x. 21797837 PMC3158286 · DOI
  54. Schonberg MA, Li V, Marcantonio ER, Davis RB, McCarthy EP. Predicting mortality up to 14 years among community-dwelling adults aged 65 and older. J Am Geriatr Soc. 2017; 65(6): 1310– 5. 10.1111/jgs.14805. 28221669 PMC5478427 Extended the validation of the Schonberg mortality index to 14 years. · DOI
  55. Suemoto CK, Ueda P, Beltran-Sanchez H, Lebrao ML, Duarte YA, Wong R, Development and validation of a 10-year mortality prediction model: meta-analysis of individual participant data from five cohorts of older adults in developed and developing countries. J Gerontol A Biol Sci Med Sci. 2017; 72(3): 410– 6. 10.1093/gerona/glw166. 27522061 PMC6075520 Developed a mortality index for older adults in developing countries. · DOI
  56. [65]Porock D, Parker-Oliver D, Petroski GF, Rantz M. The MDS mortality risk index: the evolution of a method for predicting 6-month mortality in nursing home residents. BMC Res Notes. 2010; 3: 200 10.1186/1756-0500-3-200. 20637076 PMC2913927 · DOI
  57. [66]Porock D, Oliver DP, Zweig S, Rantz M, Mehr D, Madsen R, Predicting death in the nursing home: development and validation of the 6-month Minimum Data Set mortality risk index. J Gerontol A Biol Sci Med Sci. 2005; 60(4): 491– 8. 15933390
  58. [67]Mitchell SL, Miller SC, Teno JM, Kiely DK, Davis RB, Shaffer ML. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. JAMA. 2010; 304(17): 1929– 35. 10.1001/jama.2010.1572. 21045099 PMC3017367 · DOI
  59. [68]Mitchell SL, Miller SC, Teno JM, Davis RB, Shaffer ML. The advanced dementia prognostic tool: a risk score to estimate survival in nursing home residents with advanced dementia. J Pain Symptom Manag. 2010; 40(5): 639– 51. 10.1016/j.jpainsymman.2010.02.014. PMC2981683 20621437 · DOI · Paper page
  60. [69]Flacker JM, Kiely DK. Mortality-related factors and 1-year survival in nursing home residents. J Am Geriatr Soc. 2003; 51(2): 213– 21. 12558718
  61. [70]Kruse RL, Parker Oliver D, Mehr DR, Petroski GF, Swenson DL, Zweig SC. Using mortality risk scores for long-term prognosis of nursing home residents: caution is recommended. J Gerontol A Biol Sci Med Sci. 2010; 65(11): 1235– 41. 10.1093/gerona/glq120. 20639529 · DOI
  62. Karter AJ, Warton EM, Moffet HH, Ralston JD, Huang ES, Miller DR, Revalidation of the hypoglycemia risk stratification tool using ICD-10 codes. Diabetes Care. 2019 10.2337/dc18-2154. PMC6429629 30765427 Revalidation using ICD-10 codes. · DOI · Paper page
  63. Chow LS, Zmora R, Ma S, Seaquist ER, Schreiner PJ. Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2018; 6(1): e000527 10.1136/bmjdrc-2018-000527. PMC6091902 30116541 Developed and validated a hypoglycemia risk prediction tool using clinical data. · DOI · Paper page
  64. Schroeder EB, Xu S, Goodrich GK, Nichols GA, O’Connor PJ, Steiner JF. Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: development and external validation of a prediction model. J Diabetes Complications. 2017; 31(7): 1158– 63. 10.1016/j.jdiacomp.2017.04.004. 28462891 PMC5516886 Developed and validated a hypoglycemia risk prediction tool using health systems data. · DOI
  65. [75]Palmer AJ, Mount Hood 5 Modeling G, Clarke P, Gray A, Leal J, Lloyd A, Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting. Value Health. 2013; 16(4): 670– 85. 10.1016/j.jval.2013.01.002. 23796302 · DOI
  66. [76]van Dieren S, Beulens JW, Kengne AP, Peelen LM, Rutten GE, Woodward M, Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart. 2012; 98(5): 360– 9. 10.1136/heartjnl-2011-300734. 22184101 · DOI
  67. [77]Schlessinger L, Eddy DM. Archimedes: a new model for simulating health care systems–the mathematical formulation. J Biomed Inform. 2002; 35(1): 37– 50. 12415725
  68. [78]Eddy DM, Schlessinger L. Archimedes: a trial-validated model of diabetes. Diabetes Care. 2003; 26(11): 3093– 101. 14578245
  69. [79]Eddy DM, Schlessinger L. Validation of the Archimedes diabetes model. Diabetes Care. 2003; 26(11): 3102– 10. 14578246
  70. [80]Stern M, Williams K, Eddy D, Kahn R. Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models. Diabetes Care. 2008; 31(8): 1670– 1. 10.2337/dc08-0521. 18509203 PMC2494666 · DOI
  71. [81]Saver BG, Hargraves JL, Mazor KM. Are population-based diabetes models useful for individual risk estimation? J Am Board Fam Med. 2011; 24(4): 399– 406. 10.3122/jabfm.2011.04.110029. 21737764 · DOI
  72. [82]Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjornsdottir S, Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015; 373(18): 1720– 32. 10.1056/NEJMoa1504347. 26510021 · DOI
  73. [84]Fried TR, Tinetti ME, Towle V, O’Leary JR, Iannone L. Effects of benefits and harms on older persons’ willingness to take medication for primary cardiovascular prevention. Arch Intern Med. 2011; 171(10): 923– 8. 10.1001/archinternmed.2011.32. 21357797 PMC3101287 · DOI
  74. [85]Fried TR, McGraw S, Agostini JV, Tinetti ME. Views of older persons with multiple morbidities on competing outcomes and clinical decision-making. J Am Geriatr Soc. 2008; 56(10): 1839– 44. 10.1111/j.1532-5415.2008.01923.x. 18771453 PMC2596278 · DOI · Paper page
  75. [89]Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009; 301(15): 1565– 72. 10.1001/jama.2009.460. 19366776 PMC2782622 · DOI · Paper page
  76. [92]Nicolucci A, Pintaudi B, Rossi MC, Messina R, Dotta F, Frontoni S, The social burden of hypoglycemia in the elderly. Acta Diabetol. 2015; 52(4): 677– 85. 10.1007/s00592-015-0717-0. 25663036 · DOI
  77. [93]Lipska KJ, Warton EM, Huang ES, Moffet HH, Inzucchi SE, Krumholz HM, HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013; 36(11): 3535– 42. 10.2337/dc13-0610. 23900589 PMC3816866 · DOI
  78. Lee AK, Warren B, Lee CJ, McEvoy JW, Matsushita K, Huang ES, The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes. Diabetes Care. 2018; 41(1): 104– 11. 10.2337/dc17-1669. 29127240 PMC5741158 Determined that severe hypoglycemia was strongly associated with cardiovascular events and mortality. · DOI · Paper page
  79. [95]Caverly TJ, Fagerlin A, Zikmund-Fisher BJ, Kirsh S, Kullgren JT, Prenovost K, Appropriate prescribing for patients with diabetes at high risk for hypoglycemia: National Survey of veterans affairs health care professionals. JAMA Intern Med. 2015; 175(12): 1994– 6. 10.1001/jamainternmed.2015.5950. 26502113 · DOI
  80. [96]Cresswell KM, Fernando B, McKinstry B, Sheikh A. Adverse drug events in the elderly. Br Med Bull. 2007; 83(1): 259– 74. 10.1093/bmb/ldm016. 17580312 · DOI
  81. [97]Peene B, D’Hooge D, Vandebrouck T, Mathieu C. Patient-reported frequency, awareness and patient-physician communication of hypoglycaemia in Belgium. Acta Clin Belg. 2014; 69(6): 439– 45. 10.1179/2295333714Y.0000000050. 25212241 · DOI
  82. [98]Bloomfield HE, Greer N, Newman D, MacDonald R, Carlyle M, Fitzgerald P, Predictors and consequences of severe hypoglycemia in adults with diabetes - a systematic review of the evidence. Washington (DC): VA Evidence-based Synthesis Program Reports; 2012. 23256228
  83. [100]Shorr RI, Ray WA, Daugherty JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997; 157(15): 1681– 6. 9250229
  84. [101]Lee AK, Lee CJ, Huang ES, Sharrett AR, Coresh J, Selvin E. Risk factors for severe hypoglycemia in black and white adults with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2017; 40(12): 1661– 7. 10.2337/dc17-0819. 28928117 PMC5711330 · DOI · Paper page
  85. [103]Chelliah A, Burge MR. Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs Aging. 2004; 21(8): 511– 30. 10.2165/00002512-200421080-00003. 15182216 · DOI
  86. [105]McCoy RG, Lipska KJ, Yao X, Ross JS, Montori VM, Shah ND. Intensive treatment and severe hypoglycemia among adults with type 2 diabetes. JAMA Intern Med. 2016; 176(7): 969– 78. 10.1001/jamainternmed.2016.2275. 27273792 PMC5380118 · DOI · Paper page
  87. [106]Thorpe CT, Gellad WF, Good CB, Zhang S, Zhao X, Mor M, Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia. Diabetes Care. 2015; 38(4): 588– 95. 10.2337/dc14-0599. 25592195 PMC5447267 · DOI · Paper page
  88. [107]Tseng CL, Soroka O, Maney M, Aron DC, Pogach LM. Assessing potential glycemic overtreatment in persons at hypoglycemic risk. JAMA Intern Med. 2014; 174(2): 259– 68. 10.1001/jamainternmed.2013.12963. 24322626 · DOI
  89. [108]Thai JN, Walter LC, Eng C, Smith AK. Every patient is an individual: clinicians balance individual factors when discussing prognosis with diverse frail elderly adults. J Am Geriatr Soc. 2013; 61(2): 264– 9. 10.1111/jgs.12098. 23320808 PMC3573246 · DOI
  90. [109]Cagle JG, McClymont KM, Thai JN, Smith AK. “If you don’t know, all of a sudden, they’re gone”: caregiver perspectives about prognostic communication for disabled elderly adults. J Am Geriatr Soc. 2016; 64(6): 1299– 306. 10.1111/jgs.14137. 27321609 PMC4955663 · DOI
  91. Schoenborn NL, Janssen EM, Boyd C, Bridges JFP, Wolff AC, Xue QL, Older adults’ preferences for discussing long-term life expectancy: results from a national survey. Ann Fam Med. 2018; 16(6): 530– 7. 10.1370/afm.2309. 30420368 PMC6231926 Determined that many older adults did not wish to discuss long-term life expectancy until the last 1–2 years of life. · DOI
  92. [111]Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manag. 2007; 34(1): 81– 93. 10.1016/j.jpainsymman.2006.09.035. 17531434 · DOI
  93. [112]Powell AA, Saini SD, Breitenstein MK, Noorbaloochi S, Cutting A, Fisher DA, Rates and correlates of potentially inappropriate colorectal cancer screening in the Veterans Health Administration. J Gen Intern Med. 2015; 30(6): 732– 41. 10.1007/s11606-014-3163-8. 25605531 PMC4441657 · DOI
  94. [113]Schonberg MA, Breslau ES, Hamel MB, Bellizzi KM, McCarthy EP. Colon cancer screening in U.S. adults aged 65 and older according to life expectancy and age. J Am Geriatr Soc. 2015; 63(4): 750– 6. 10.1111/jgs.13335. 25900488 · DOI
  95. [114]Drazer MW, Prasad SM, Huo D, Schonberg MA, Dale W, Szmulewitz RZ, National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer. 2014; 120(10): 1491– 8. 10.1002/cncr.28600. 24523016 · DOI
  96. [115]Schonberg MA, Breslau ES, McCarthy EP. Targeting of mammography screening according to life expectancy in women aged 75 and older. J Am Geriatr Soc. 2013; 61(3): 388– 95. 10.1111/jgs.12123. 23414437 PMC3602282 · DOI
  97. [116]Schoenborn NL, Huang J, Sheehan OC, Wolff JL, Roth DL, Boyd CM. Influence of age, health, and function on cancer screening in older adults with limited life expectancy. J Gen Intern Med. 2019; 34(1): 110– 7. 10.1007/s11606-018-4717-y. 30402822 PMC6318172 · DOI
  98. Schoenborn NL, Lee K, Pollack CE, Armacost K, Dy SM, Bridges JFP, Older adults’ views and communication preferences about cancer screening cessation. JAMA Intern Med. 2017; 177(8): 1121– 8. 10.1001/jamainternmed.2017.1778. 28604917 PMC5564296 Clarified the views of older patients on using life expectancy to individualize cancer screening decisions. · DOI
  99. [118]Gross CP, Fried TR, Tinetti ME, Ross JS, Genao I, Hossain S, Decision-making and cancer screening: a qualitative study of older adults with multiple chronic conditions. J Geriatr Oncol. 2015; 6(2): 93– 100. 10.1016/j.jgo.2014.12.001. 25544380 · DOI
  100. [119]Lewis CL, Kistler CE, Amick HR, Watson LC, Bynum DL, Walter LC, Older adults’ attitudes about continuing cancer screening later in life: a pilot study interviewing residents of two continuing care communities. BMC Geriatr. 2006; 6: 10 10.1186/1471-2318-6-10. 16887040 PMC1559693 · DOI
  101. [120]Markovitz AA, Hofer TP, Froehlich W, Lohman SE, Caverly TJ, Sussman JB, An examination of deintensification recommendations in clinical practice guidelines: stepping up or scaling back? JAMA Intern Med. 2018; 178(3): 414– 6. 10.1001/jamainternmed.2017.7198. 29255902 PMC5885915 · DOI
  102. Maciejewski ML, Mi X, Sussman J, Greiner M, Curtis LH, Ng J, Overtreatment and deintensification of diabetic therapy among Medicare beneficiaries. J Gen Intern Med. 2018; 33(1): 34– 41. 10.1007/s11606-017-4167-y. 28905179 PMC5756160 Determined that deintensification of diabetes treatment is unusual in tightly controlled older adults. · DOI
  103. [122]Sussman JB, Kerr EA, Saini SD, Holleman RG, Klamerus ML, Min LC, Rates of deintensification of blood pressure and glycemic medication treatment based on levels of control and life expectancy in older patients with diabetes mellitus. JAMA Intern Med. 2015; 175(12): 1942– 9. 10.1001/jamainternmed.2015.5110. 26502220 PMC9617259 · DOI · Paper page
  104. McAlister FA, Youngson E, Eurich DT. Treatment deintensification is uncommon in adults with type 2 diabetes mellitus: a retrospective cohort study. Circ Cardiovasc Qual Outcomes. 2017; 10(4). doi: 10.1161/CIRCOUTCOMES.116.003514. 28416531 Determined that deintensification of diabetes treatment is unusual in tightly controlled and frail older adults. · DOI · Paper page
  105. [124]Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013; 61(9): 1508– 14. 10.1111/jgs.12418. 24028356 · DOI
  106. [125]Turner JP, Tannenbaum C. Older adults’ awareness of deprescribing: a population-based survey. J Am Geriatr Soc. 2017; 65(12): 2691– 6. 10.1111/jgs.15079. 28913911 PMC5763385 · DOI
  107. [126]Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013; 30(10): 793– 807. 10.1007/s40266-013-0106-8. 23912674 · DOI · Paper page
  108. Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians’ views on deprescribing in everyday practice. Ann Fam Med. 2017; 15(4): 341– 6. 10.1370/afm.2094. 28694270 PMC5505453 · DOI
  109. [128]Linsky A, Simon SR, Marcello TB, Bokhour B. Clinical provider perceptions of proactive medication discontinuation. Am J Manag Care. 2015; 21(4): 277– 83. 26014466 Identified numerous barriers to deprescribing in primary care.
  110. Petrillo LA, Gan S, Jing B, Lang-Brown S, Boscardin WJ, Lee SJ. Hypoglycemia in hospice patients with type 2 diabetes in a national sample of nursing homes. JAMA Intern Med. 2018; 178(5): 713– 5. 10.1001/jamainternmed.2017.7744. 29279891 PMC5885911 Identified substantial rates of high-risk diabetes medication use and hypoglycemia among patients on hospice. · DOI · Paper page
  111. Huang ES, Nathan AG, Cooper JM, Lee SM, Shin N, John PM, Impact and feasibility of personalized decision support for older patients with diabetes: a pilot randomized trial. Med Decis Making. 2017; 37(5): 611– 7. 10.1177/0272989X16654142. 27311651 PMC5161732 A promising pilot trial of a diabetes decision support tool incorporating personalized risk prediction. · DOI

Cited by

Sorted by citations

Authors
Pilla, S. J., Schoenborn, N. L., Maruthur, N. M., & Huang, E. S.
Affiliations
  • Johns Hopkins University (US)
  • University of Chicago (US)
Corresponding author
Pilla, Scott J.
ORCID
Venue
Current Diabetes Reports
Publisher
Springer Science and Business Media LLC
Published
2019-07-19
Volume
19
Issue
8
Pages
59-59
ISSN
  • 1534-4827 (ISSN-L)
  • 1539-0829
DOI
10.1007/s11892-019-1172-z
PMC
PMC7307417
OpenAlex
W2963410178
Cited by
24
References
18
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 6 · 2022: 4 · 2021: 3 · 2020: 5
FWCI
0.46
Type
journal article
Language
en
Open access
Licence
Locations
  • Current Diabetes Reports (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (U01 DK57149, K24 DK105340, R56 AG051683, P30 DK092949)
  • National Institutes on Aging (K76 AG059984)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
diabetes in older adults, risk assessment, life expectancy estimation, glycemic targets, hypoglycemia risk, adverse drug reactions, prognostic tools, individualized care, patient-centered care, clinical guidelines
MeSH terms
Blood Glucose, Diabetes Mellitus, Humans, Hypoglycemia, Hypoglycemic Agents, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review